Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407082 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
A Phase 2 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 2
- Development phase
- 278
- Enrollment target
NCT00407082: Completed Phase 2 study, sponsored by Bausch & Lomb Incorporated.
NCT00407082 is a Phase 2 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 278 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (109% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00407082, a Phase 2 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 278 participants
- Enrollment target
Study Summary
This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.
Interventions
- DRUG fluocinolone acetonide intravitreal implant
- DRUG Fluocinolone acetonide 2.1mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2000-12 |
| Est. Completion | 2005-09 |
| Phase | Phase 2 |
What the finished NCT00407082 record still lists
NCT00407082 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (109% higher).
The record links to 0 conditions, and to 2 interventions - of which fluocinolone acetonide intravitreal implant is the first listed.
NCT00407082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00407082 about?
NCT00407082 is a clinical study titled "Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants". This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare th...
What is the current status of trial NCT00407082?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 278 participants. The study started on 2000-12. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00407082?
The interventions under investigation include: fluocinolone acetonide intravitreal implant (DRUG), Fluocinolone acetonide 2.1mg (DRUG).
Who is sponsoring clinical trial NCT00407082?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00407082's enrollment target sits among peer trials
278 202nd of 2000 higher than 1,799 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia